Dr. Faragher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1700 S Potomac St
Aurora, CO 80012Phone+1 303-418-7600Fax+1 303-750-3137
Education & Training
National Capital ConsortiumFellowship, Hematology and Medical Oncology, 1986 - 1989
Fitzsimons Army Medical CenterResidency, Internal Medicine, 1983 - 1986
University of South Dakota, Sanford School of MedicineClass of 1983
Certifications & Licensure
CO State Medical License 1992 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 5 citationsAn open-label pilot study of pentostatin, mitoxantrone, and rituximab in patients with previously untreated, Stage III or IV, low-grade non-Hodgkin lymphomaNicholas J. Di Bella, Craig W. Reynolds, David C. Faragher, Joseph Muscato, Kristi A. Boehm
Cancer. 2005-03-01 - 10 citationsResults of a Phase II Multicenter Trial of Pentostatin and Rituximab in Patients with Low-Grade B-Cell Non-Hodgkin's Lymphoma: An Effective and Minimally Toxic RegimenRobert Drapkin, Nicholas J. Di Bella, David C. Faragher, Elizabeth Harden, Carmen Matei
Clinical Lymphoma. 2003-12-01
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
